Cephalalgia

Article	Citations
Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution	162
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	88
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention	79
Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia	71
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine	70
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study	70
Isolated intracranial hypertension associated with COVID-19	70
Migraine therapeutics differentially modulate the CGRP pathway	67
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis	60
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	59
Phenotypic characterization of acute headache attributed to SARS-CoV-2: An ICHD-3 validation study on 106 hospitalized patients	58
The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study	52
Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis	48
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	46
Prevalence of neck pain in migraine: A systematic review and meta-analysis	46
Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study	46
Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: A cross sectional study	45
Clinical, oculographic, and vestibular test characteristics of vestibular migraine	45
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children	44
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis	43
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study	43
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study	43
A systematic review of treatment for patients with burning mouth syndrome	41
Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database	41
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study	40

The role of cytokines in migraine: A systematic review	39
Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian/Asiatic flu	39
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study	37
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial	36
CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine	36
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study	36
E-diary use in clinical headache practice: A prospective observational study	36
Incidence of spontaneous intracranial hypotension in a community: Beverly Hills, California, 2006–2020	35
Diagnosis and treatment of idiopathic intracranial hypertension	34
Sex differences in prevalence of migraine trigger factors: A cross-sectional study	32
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks	31
The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic	29
Photophobia in migraine: A symptom cluster?	27
Two hundred and forty-eight cases of visual snow: A review of potential inciting events and contributing comorbidities	27
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons	27
Interictal amylin levels in chronic migraine patients: A case-control study	27
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review	26
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label ext	25
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection	25
Hypersensitivity to calcitonin gene-related peptide in chronic migraine	25
Post-traumatic headache due to mild traumatic brain injury: Current knowledge and future directions	25
Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society	25
Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial	24
Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache	23
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache	23
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	23
Pre-treatment non-ictal cephalic allodynia identifies responders to prophylactic treatment of chronic and episodic migraine patients with galcanezumab: A prospective quantitative sensory testing study	23
The migraine postdrome: Spontaneous and triggered phenotypes	22
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study	22
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II	22
Prevalence and risk factors of migraine and non-migraine headache in older people – results of the Heinz Nixdorf Recall study	22
Functional magnetic resonance imaging in migraine: A systematic review	21
How does the brain change in chronic migraine? Developing disease biomarkers	21
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	21
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	21
Prevalence and characteristics of Alice in Wonderland Syndrome in adult migraineurs: Perspectives from a tertiary referral headache unit	20
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19	20
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data	20
Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-ana	20
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine	19
Premonitory symptoms in migraine from China: A multi-clinic study of 4821 patients	19
Validation of diagnostic ICHD-3 criteria for menstrual migraine	19
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine	19
Prevalence of pre-cluster symptoms in episodic cluster headache: Is it possible to predict an upcoming bout?	19
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	19
Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data	19
CGRP measurements in human plasma – a methodological study	19
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature	18
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	18
Combination of acupuncture and medical training therapy on tension type headache: Results of a randomised controlled pilot study	18

Atogepant – an orally-administered CGRP antagonist – attenuates activation of meningeal nociceptors by CSD	17
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	17
Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunt	17
Real-life treatment of cluster headache in a tertiary headache center – results from the Danish Cluster Headache Survey	17
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications	17
The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice	17
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy	17
Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases	17
Atrial fibrillation and migraine with aura in young adults with ischemic stroke	17
Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks	17
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	17
A prolactin-dependent sexually dimorphic mechanism of migraine chronification	17
The prevalence of headache disorders in children and adolescents in Iran: a schools-based study	17
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients	16
“Idiopathic” intracranial hypertension: An update from neurointerventional research for clinicians	16
No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	15
Clinical correlates of hypothalamic functional changes in migraine patients	15
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	15
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria	15
A national Swedish case-control study investigating incidence and factors associated with idiopathic intracranial hypertension	15
TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine	15
Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis	15
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	15
Time to retire ‘New daily persistent headache’: Mode of onset of chronic migraine and tension-type headache	14
Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic	14
Neurovascular contact plays no role in trigeminal neuralgia secondary to multiple sclerosis	14
Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial	14
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	14
Reversible cerebral vasoconstriction syndrome developing after an erenumab injection for migraine prevention	14
Muscle endurance training of the neck triggers migraine attacks	14
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	14
Poor social support and loneliness in chronic headache: Prevalence and effect modifiers	14
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials	13
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis	13
Twenty-five years of triptans – a nationwide population study	13
Update in the understanding of new daily persistent headache	13
Identification of work accommodations and interventions associated with work productivity in adults with migraine: A scoping review	13
Measuring health-related quality of life in chronic headache: A comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6)	13
Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden	13
Migraine genetics: Status and road forward	12
Pain in the temple? Headache, muscle pain or both: A retrospective analysis	12
The time sequence of brain MRI findings in spontaneous intracranial hypotension	12
Forecasting migraine with machine learning based on mobile phone diary and wearable data	12
Epidemiology, burden and clinical spectrum of cluster headache: a global update	12
Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study	12
Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine	12
Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences	11
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients	11
Effect of single dose Erenumab on cortical responses evoked by cutaneous a-delta fibers: A pilot study in migraine patients	11
The molecular clock gene cryptochrome 1 (CRY1) and its role in cluster headache	11
Update on headache and brain tumors	11
Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial	11
Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2	11
Headache characteristics and postoperative course in Chiari I malformation	11
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees	11
Sex-related differences in cluster headache: A hospital-based study in Taiwan	11
Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial	11
Targeting reactive nitroxidative species in preclinical models of migraine	11
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	11
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia	11
New daily persistent headache: A systematic review and meta-analysis	10
Occipital ischaemic stroke after visual snow phenomenon – a case report	10
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	10
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	10
Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response	10
Calcitonin receptor antibody validation and expression in the rodent brain	10
Trans-nasal high-flow dehumidified air in acute migraine headaches: A randomized controlled trial	10
Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies	10
Evaluation and treatment of headache associated with moyamoya disease – a narrative review	10
De novo protein synthesis is necessary for priming in preclinical models of migraine	10
A systematic evaluation of primary headache management apps leveraging behavior change techniques	10
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	10
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	10
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm	9
Diagnosis and classification of headache associated with sexual activity using a composite algorithm: A cohort study	9
Prolactin in headache and migraine: A systematic review of clinical studies	9
Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients	9
Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura	9

The headache and aura-inducing effects of sildenafil in patients with migraine with aura	9
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	9
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	9
Preventive effect of greater occipital nerve block on patients with episodic migraine: A randomized double‐blind placebo‐controlled clinical trial	9
Polypharmacy and comorbidities during pregnancy in a cohort of women with migraine	9
Association and genetic overlap between clinical chemistry tests and migraine	9
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	9
Primary headache disorders in Latin America and the Caribbean: A meta-analysis of population-based studies	9
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	8
Headache secondary to cerebrovascular disease	8
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine	8
Is pituitary MRI screening necessary in cluster headache?	8
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature	8
Efficacy of lasmiditan for the acute treatment of perimenstrual migraine	8
Transorbital sonography: A non-invasive bedside screening tool for detection of pseudotumor cerebri syndrome	8
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	8
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	8
Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial	8
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study	8
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	8
The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses	8
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	8
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	8
Telemedicine in headache care: A systematic review	8
Validity of the Severity of Dependence Scale for detecting dependence behaviours in chronic migraine with medication overuse	8
Migraine with and without aura in relation to the menstrual cycle and other hormonal milestones: A prospective cohort study	8
Pain thresholds and suprathreshold pain after sleep restriction in migraine – A blinded crossover study	8
Could erectile dysfunction be a side effect of CGRP inhibition? A case report	8
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	8
Epicranial headaches part 2: Nummular headache and epicrania fugax	8
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache	7
Shared genetics and causal relationships between migraine and thyroid function traits	7
Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study	7
TRESK background potassium channel modifies the TRPV1-mediated nociceptor excitability in sensory neurons	7
Prevalence and clinical features of hemicrania continua in clinic-based studies: A systematic review and meta-analysis	7
Indirect costs attributed to headache: A nation-wide survey of an active working population	7
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial	7
Hypnic Headache – What do we know in 2022?	7
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	7
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	7
The spectrum of indomethacin-responsive headaches in children and adolescents	7
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	7
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions	7
A brief diagnostic screen for cluster headache: Creation and initial validation of the Erwin Test for Cluster Headache	7
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach	7
OnabotulinumtoxinA effects on trigeminal nociceptors	7
Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?	7
P3 latency as a biomarker for the complexity of migraine with aura: Event-related potential study	7
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	7
SUNCT/SUNA: Case series presenting in an orofacial pain clinic	7
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache	7
The prevalence and characteristics of visceral autonomic symptoms among migraineurs: A population-based study	6
Severe abrupt (thunderclap) non-traumatic headache at the pediatric emergency department – a retrospective study	6
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine	6
The burden of migraine on acute and emergency services in a London teaching hospital	6
Successful treatment of primary headache associated with sexual activity using erenumab: Case report	6
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	6
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	6
What do patients’ efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry	6
Epicranial headache part 1: Primary stabbing headache	6
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	6
Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: A report of two cases	6
T2* reduction in patients with acute post-traumatic headache	6
Insufficient sleep may alter cortical excitability near the migraine attack: A blinded TMS crossover study	6
Bimodal sensory integration in migraine: A study of the effect of visual stimulation on somatosensory evoked cortical responses	6
Efficacy of surgical treatment in patients with trigeminal neuralgia secondary to multiple sclerosis: A prospective study of 18 cases with evaluation of outcome and complications by independent evalu	6
Headaches and the use of personal protective equipment in the general population during the COVID-19 pandemic	6
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	6
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	6
Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood	6
Clinical analysis of 30 cases of cardiac cephalalgia	6
Patients with episodic migraine show increased T2 values of the trapezius muscles – an investigation by quantitative high-resolution magnetic resonance imaging	6
The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea	6
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	6
Transient loss of interhemispheric functional connectivity following unilateral cortical spreading depression in awake rats	6
Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study	6
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	6
Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: A systematic review and meta-analysis	6
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population	5
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	5
Abstracts from the International Headache Congress 14–17 September 2023	5
Delivery of care for migraine in the Asian Oceanian region: A cross-sectional study	5
Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache	5
Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review	5
Mesocorticolimbic system abnormalities in chronic cluster headache patients: A neural signature?	5
Update on headaches associated with physical exertion	5
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	5
Head/neck pain characteristics after spontaneous cervical artery dissection in the acute phase and on a long-run	5
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A systematic review and meta-analysis	5
The genetics and chronobiology of cluster headache	5
Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome	5
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine	5
Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study	5
Headache provocation by nitric oxide in men who have never experienced a headache	5
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	5